Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells

D M Simeone1, L Zhang, K Graziano

  • 1Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA. simeone@umich.edu

Insights

Transforming growth factor-beta (TGF-beta) activates MAP kinases, including ERKs and p38, in pancreatic acinar cells. This activation is Smad-dependent and biologically relevant, impacting gene transcription.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Gastroenterology

Background:

  • Transforming growth factor-beta (TGF-beta) is a key regulator of cell growth, often inhibiting it.
  • Smad proteins are central mediators of TGF-beta signaling in many cell types.
  • Potential interactions between Smad and mitogen-activated protein (MAP) kinase pathways are increasingly recognized.

Purpose of the Study:

  • To investigate the interplay between TGF-beta and MAP kinase signaling in rat pancreatic acinar cells.
  • To elucidate the specific MAP kinases activated by TGF-beta in this cell type.
  • To determine the role of Smad proteins in mediating TGF-beta-induced MAP kinase activation.

Main Methods:

  • Treatment of isolated rat pancreatic acinar cells with TGF-beta.
  • Analysis of MAP kinase activities (ERK, p38, JNK) via Western blotting or kinase assays.
  • Use of specific inhibitors (PD-98059) and adenoviral vectors for dominant-negative constructs (RasN17, Smad4).
  • Assessment of transcription factor activation (AP-1).

Main Results:

  • TGF-beta activated extracellular signal-related kinases (ERKs) and p38, but not c-jun NH2-terminal kinase.
  • MAP kinase activation by TGF-beta was time-dependent (maximal at 4 hours), concentration-dependent, and required protein synthesis.
  • Inhibition of MAP kinase kinase 1 (MEK1) or expression of dominant-negative RasN17 blocked ERK activation.
  • Adenoviral expression of dominant-negative Smad4 abrogated TGF-beta-induced MAP kinase activation, indicating it is downstream of Smads.
  • Inhibition of ERK signaling by PD-98059 blocked TGF-beta-induced activation of activator protein-1 (AP-1).

Conclusions:

  • TGF-beta activates ERKs and p38 in pancreatic acinar cells through a Smad-dependent pathway.
  • This activation is a crucial step in mediating TGF-beta's biological effects, including the regulation of transcription factors like AP-1.
  • These findings provide novel insights into the molecular mechanisms of TGF-beta signaling in pancreatic acinar cells.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...